Health officials are reminding the public that antibiotics are ineffective against respiratory infections caused by viruses, ...

Respiratory virus season is quickly approaching, meaning we will start to see cold, flu, COVID, and RSV in our community. The ...

Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.

Royalty-free licenses let you pay once to use copyrighted images and video clips in personal and commercial projects on an ongoing basis without requiring additional payments each time you use that ...

Respiratory virus data included in the interactive data application is up-to-date as of September 14, 2024. Among its new features, the dashboard now includes RSV Severe Outcomes data.

Vaccination against respiratory syncytial virus for adults over 60 is likely to be cost-effective by preventing illness, ...

RSV, or respiratory syncytial virus, is a common cause of coughs and colds which can also lead to severe lung infections like pneumonia and infant bronchiolitis – conditions which are highly ...

The battle against antimicrobial resistance (AMR) demands critical evaluation of antibiotic treatment protocols, particularly for respiratory tract infections (RTIs). The umbrella review in The Lancet ...

You will be able to get a free RSV vaccination because you’re aged 75 to 79 years (or recently turned 80). Every year, thousands of people in your age group need hospital care for RSV infection. RSV ...

Respiratory virus season is right around the corner. Although rates are still nowhere close to where they were during 2022’s omicron wave, percent positivity remains high and was higher in late ...

NHS will roll out a one-time “catch-up” RSV vaccine campaign for individuals aged 75 to 79 years. Credit: MargJohnsonVA/Shutterstock. The UK National Health ...